When other efforts fail, glucagon-like peptide-1 (GLP-1) drugs, such as Ozempic and Wegovy, may be able to help
How long does it take for fainting risk to decrease after starting semaglutide
Use In Specific Populations 8.1 Pregnancy Risk Summary Published studies with use of insulin glargine products during pregnancy have not reported a clear association with insulin glargine products and adverse developmental outcomes (see Data)
Conclusion GLP-1 is more than just a weight-loss aid
The medication may help reduce physical hunger and sugar cravings, but the coaching and science-backed lessons are there to help with the everyday stuff, like making better food choices, staying consistent, building confidence, and creating a healthier relationship with food and movement
The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis Zhu, Kai, et al (2023) Efficacy and safety of semaglutide in non-alcoholic fatty liver disease Gastalldeli, Amalia, et al